EDGAR Filing Documents for 0001558370-24-002475

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-24-002475

Filing Date

2024-03-05

Accepted

2024-03-05 16:06:00

Documents

101

Period of Report

2023-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	rigl-20231231x10k.htm iXBRL	10-K	3041452
2	EX-10.9	rigl-20231231xex10d9.htm	EX-10.9	143024
3	EX-23.1	rigl-20231231xex23d1.htm	EX-23.1	14685
4	EX-31.1	rigl-20231231xex31d1.htm	EX-31.1	14909
5	EX-31.2	rigl-20231231xex31d2.htm	EX-31.2	14993
6	EX-32.1	rigl-20231231xex32d1.htm	EX-32.1	10082
7	EX-97	rigl-20231231xex97.htm	EX-97	44705
8	GRAPHIC	rigl-20231231x10k003.jpg	GRAPHIC	76954
9	GRAPHIC	rigl-20231231x10k004.jpg	GRAPHIC	28560
	Complete submission text file	0001558370-24-002475.txt		12498399

Data Files

Seq	Description	Document	Type	Size
10	EX-101.SCH	rigl-20231231.xsd	EX-101.SCH	77845
11	EX-101.CAL	rigl-20231231_cal.xml	EX-101.CAL	76006
12	EX-101.DEF	rigl-20231231_def.xml	EX-101.DEF	284793
13	EX-101.LAB	rigl-20231231_lab.xml	EX-101.LAB	678547
14	EX-101.PRE	rigl-20231231_pre.xml	EX-101.PRE	497329
103	EXTRACTED XBRL INSTANCE DOCUMENT	rigl-20231231x10k_htm.xml	XML	2224001

Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080

Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100

RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)